Trials / Withdrawn
WithdrawnNCT01395381
Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition
Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Benefit of Antihelminthic Therapy in the Community-Based Treatment of Severe Acute Malnutrition in Malawian Children
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 6 Months – 59 Months
- Healthy volunteers
- Not accepted
Summary
The benefit of anti-worm therapy as part of the case management of severe acute malnutrition (SAM) in the outpatient setting has not previously been studied. This study will compare recovery rates of children with SAM treated in the community with locally-produced ready-to-use therapeutic food (RUTF) with and without prescribed albendazole as part of their case management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | placebo given once |
| DRUG | Albendazole | single dose albendazole given at the time of enrollment |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2014-01-01
- First posted
- 2011-07-15
- Last updated
- 2014-01-28
Locations
1 site across 1 country: Malawi
Source: ClinicalTrials.gov record NCT01395381. Inclusion in this directory is not an endorsement.